{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:09:54Z","timestamp":1794020994179,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013910","name":"University of the Chinese Academy of Sciences Wenzhou Institute","doi-asserted-by":"publisher","award":["WIUCASQD2019009"],"award-info":[{"award-number":["WIUCASQD2019009"]}],"id":[{"id":"10.13039\/501100013910","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.actbio.2025.02.006","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T01:44:58Z","timestamp":1738806298000},"page":"307-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A promising strategy for ocular noninvasive protein delivery: The case in treating corneal neovascularization"],"prefix":"10.1016","volume":"196","author":[{"given":"Bangxun","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0492-2913","authenticated-orcid":false,"given":"Xingjie","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinxiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.actbio.2025.02.006_bib0001","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.actbio.2025.02.006_bib0002","first-page":"15","article-title":"Corneal neovascularization: updates on pathophysiology, investigations & management, romanian","volume":"63","author":"Sharif","year":"2019","journal-title":"Journal of ophthalmology"},{"issue":"1","key":"10.1016\/j.actbio.2025.02.006_bib0003","article-title":"Targeted dexamethasone nano-prodrug for corneal neovascularization management","volume":"47","author":"Qichuan","year":"2024","journal-title":"Biomed J"},{"key":"10.1016\/j.actbio.2025.02.006_bib0004","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jconrel.2024.07.012","article-title":"Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization","volume":"372","author":"Xiang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.actbio.2025.02.006_bib0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/d41573-021-00079-7","article-title":"FDA approves 100th monoclonal antibody product","volume":"7","author":"Mullard","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"20","key":"10.1016\/j.actbio.2025.02.006_bib0006","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and Bevacizumab for neovascular age-related","volume":"364","author":"Group","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2025.02.006_bib0007","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.addr.2017.04.001","article-title":"Nanoparticles for drug delivery to the anterior segment of the eye","volume":"122","author":"Janagam","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.actbio.2025.02.006_bib0008","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtos.2014.10.003","article-title":"Barrier function in the ocular surface: from conventional paradigms to new opportunities","volume":"13","author":"Leong","year":"2015","journal-title":"Ocul Surf"},{"key":"10.1016\/j.actbio.2025.02.006_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jtos.2023.08.001","article-title":"Molecular nature of ocular surface barrier function, diseases that affect it, and its relevance for ocular drug delivery","volume":"30","author":"Kaur","year":"2023","journal-title":"Ocul Surf"},{"key":"10.1016\/j.actbio.2025.02.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108089","article-title":"Corneal wound healing","volume":"197","author":"Wilson","year":"2020","journal-title":"Exp. Eye Res"},{"key":"10.1016\/j.actbio.2025.02.006_bib0011","series-title":"Anatomy of the Eye and the Role of Ocular Mucosa in Drug Delivery","first-page":"39","author":"Morrison","year":"2014"},{"issue":"3","key":"10.1016\/j.actbio.2025.02.006_bib0012","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II tear film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.actbio.2025.02.006_bib0013","first-page":"264","article-title":"Determination of tear volume and tear flow","volume":"5","author":"Mishima","year":"1966","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.actbio.2025.02.006_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109006","article-title":"Topical ocular drug delivery systems: innovations for an unmet need","volume":"218","author":"Yang","year":"2022","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.actbio.2025.02.006_bib0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ophtha.2011.01.041","article-title":"Horizons in therapy for corneal angiogenesis","volume":"118","author":"Maddula","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2025.02.006_bib0016","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.actbio.2020.01.008","article-title":"Multifunctional carboxymethyl chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye","volume":"104","author":"Wang","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.actbio.2025.02.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112212","article-title":"Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases","volume":"127","author":"Fang","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"20","key":"10.1016\/j.actbio.2025.02.006_bib0018","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1039\/D1TB00229E","article-title":"Bioadhesive glycosylated nanoformulations for extended trans-corneal drug delivery to suppress corneal neovascularization","volume":"9","author":"Zhang","year":"2021","journal-title":"J Mater Chem B"},{"issue":"23","key":"10.1016\/j.actbio.2025.02.006_bib0019","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1039\/D0TB00874E","article-title":"Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization","volume":"8","author":"Han","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.actbio.2025.02.006_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122081","article-title":"An injectable thermosensitive hydrogel for dual delivery of diclofenac and Avastin(R) to effectively suppress inflammatory corneal neovascularization","volume":"625","author":"Shi","year":"2022","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.actbio.2025.02.006_bib0021","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/pharmaceutics13020258","article-title":"Assessment of In-situ gelling microemulsion systems upon temperature and dilution condition for corneal delivery of Bevacizumab","volume":"13","author":"Peira","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.actbio.2025.02.006_bib0022","article-title":"Nanomicelle-assisted targeted ocular delivery with enhanced antiinflammatory efficacy In vivo","volume":"5","author":"Weng","year":"2018","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.actbio.2025.02.006_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","article-title":"Advances and limitations of drug delivery systems formulated as eye drops","volume":"321","author":"Jumelle","year":"2020","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.actbio.2025.02.006_bib0024","doi-asserted-by":"crossref","first-page":"eabq3104","DOI":"10.1126\/sciadv.abq3104","article-title":"Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment","volume":"9","author":"Shen","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2025.02.006_bib0025","first-page":"1","article-title":"Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications","volume":"11","author":"Kalomiraki","year":"2016","journal-title":"Int J Nanomedicine"},{"issue":"36","key":"10.1016\/j.actbio.2025.02.006_bib0026","doi-asserted-by":"crossref","first-page":"10583","DOI":"10.1002\/anie.201505437","article-title":"Protein delivery system containing a nickel-immobilized polymer for multimerization of affinity-purified his-tagged proteins enhances cytosolic transfer","volume":"54","author":"Postupalenko","year":"2015","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.actbio.2025.02.006_bib0027","article-title":"Cell penetrating peptide TAT-functionalized liposomes for efficient ophthalmic delivery of flurbiprofen: penetration and its underlying mechanism, retention, anti-inflammation and biocompatibility","volume":"598","author":"Wua","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.actbio.2025.02.006_bib0028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2015.10.012","article-title":"Nanotechnology for protein delivery: overview and perspectives","volume":"240","author":"Yu","year":"2016","journal-title":"Journal of Controlled Release"},{"issue":"5","key":"10.1016\/j.actbio.2025.02.006_bib0029","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1167\/iovs.16-20072","article-title":"Topical delivery of anti-VEGF drugs to the ocular posterior segment using cell-penetrating peptides","volume":"58","author":"de Cogan","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.actbio.2025.02.006_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202302765","article-title":"Aflibercept loaded eye-drop hydrogel mediated with cell-penetrating peptide for corneal neovascularization treatment","volume":"20","author":"Zhou","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.actbio.2025.02.006_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121361","article-title":"Glycopeptide-nanotransforrs eyedrops with enhanced permeability and retention for preventing fundus neovascularization","volume":"281","author":"Li","year":"2022","journal-title":"Biomaterials"},{"issue":"32","key":"10.1016\/j.actbio.2025.02.006_bib0032","article-title":"Arginine-rich cell-penetrating peptides induce lipid rearrangements for their active translocation across laterally heterogeneous membranes","volume":"11","author":"Park","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.actbio.2025.02.006_bib0033","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.actbio.2019.03.058","article-title":"Hexahistidine-metal assemblies: a promising drug delivery system","volume":"90","author":"Huang","year":"2019","journal-title":"Acta Biomater"},{"issue":"25","key":"10.1016\/j.actbio.2025.02.006_bib0034","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1039\/C8TB00312B","article-title":"A facile and efficient strategy to encapsulate the model basic protein lysozyme into porous CaCO(3)","volume":"6","author":"Shi","year":"2018","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.actbio.2025.02.006_bib0035","article-title":"Deliver protein across bio-barriers via hexa-histidine metal assemblies for therapy: a case in corneal neovascularization model","volume":"12","author":"Xu","year":"2021","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.actbio.2025.02.006_bib0036","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.actbio.2022.09.029","article-title":"Decorating hexahistidine-metal assemblies with tyrosine enhances the ability of proteins to pass through corneal biobarriers","volume":"153","author":"Tang","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.actbio.2025.02.006_bib0037","article-title":"Enhanced ocular delivery ofBeva via ultra-small polymeric micelles for noninvasive anti-VEGF therapy","volume":"32","author":"Yang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2025.02.006_bib0038","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.aca.2016.08.014","article-title":"Determination of the composition, encapsulation efficiency and loading capacity in protein drug delivery systems using circular dichroism spectroscopy","volume":"937","author":"Peng","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.actbio.2025.02.006_bib0039","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1021\/acsnano.3c12203","article-title":"Engineering matrix-free drug protein nanoparticles with promising penetration through biobarriers for treating corneal neovascularization","volume":"18","author":"Xu","year":"2024","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.actbio.2025.02.006_bib0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2005.05.132","article-title":"Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy","volume":"333","author":"Ferrara","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.actbio.2025.02.006_bib0041","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1367-5931(02)00369-1","article-title":"Protein and peptide secondary structure and conformational determination with vibrational circular dichroism","volume":"6","author":"Keiderling","year":"2002","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.actbio.2025.02.006_bib0042","article-title":"An update - prolonging the action of protein and peptide drugs","volume":"61","author":"Cao","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"10.1016\/j.actbio.2025.02.006_bib0043","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","article-title":"Endothelial cell migration during angiogenesis","volume":"100","author":"Lamalice","year":"2007","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.actbio.2025.02.006_bib0044","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10456-009-9146-4","article-title":"The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art","volume":"12","author":"Arnaoutova","year":"2009","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.actbio.2025.02.006_bib0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000268009","article-title":"Combined non-steroidal therapy in experimental corneal","volume":"29","author":"Laria","year":"1997","journal-title":"Ophthalmic Res."},{"issue":"1","key":"10.1016\/j.actbio.2025.02.006_bib0046","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s42003-023-04939-3","article-title":"Inflammatory cells dynamics control neovascularization and tissue healing after localized radiation induced injury in mice","volume":"6","author":"Loinard","year":"2023","journal-title":"Commun Biol"},{"issue":"2","key":"10.1016\/j.actbio.2025.02.006_bib0047","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Romanian Journal of Morphology and Embryology"},{"issue":"1","key":"10.1016\/j.actbio.2025.02.006_bib0048","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s42004-020-00397-8","article-title":"Extracellular protein degradation via the lysosome","volume":"3","author":"Eldeeb","year":"2020","journal-title":"Commun Chem"},{"issue":"43","key":"10.1016\/j.actbio.2025.02.006_bib0049","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1039\/C8TB00967H","article-title":"The great escape: how cationic polyplexes overcome the endosomal barrier","volume":"6","author":"Bus","year":"2018","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.actbio.2025.02.006_bib0050","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.actbio.2025.02.006_bib0051","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diff.2023.02.002","article-title":"Corneal epithelial development and homeostasis","volume":"132","author":"Swamynathan","year":"2023","journal-title":"Differentiation"},{"issue":"8","key":"10.1016\/j.actbio.2025.02.006_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"issue":"4","key":"10.1016\/j.actbio.2025.02.006_bib0053","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1083\/jcb.134.4.1031","article-title":"Matter, functional dissociation of paracellular permeability","volume":"134","author":"Balda","year":"1996","journal-title":"J. Cell Biol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:59:39Z","timestamp":1762556379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":53,"alternative-id":["S1742706125000911"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.02.006","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A promising strategy for ocular noninvasive protein delivery: The case in treating corneal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}